カテゴリー： QYResearch, 世界

世界の腎細胞がん薬市場

◆英語タイトル：Global Renal Cell Cacinoma Drugs Market Professional Survey Report 2019
◆商品コード：DATA909X14276
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：113
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、腎細胞がん薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Sutent（スニチニブ）、Nexavar（ソラフェニブ）、Votrient（パゾパニブ）、Avastin（ベバシズマブ）、Afinitor（エベロリムス）、Inlyta（アキシチニブ）、Torisel（テムシロリムス）、Proleukin（アルデスロイキン）に、用途別には、粘液性尿細管および紡錘細胞癌（MTSCC）、多房性嚢胞性明細胞腎細胞癌、尿細管嚢胞腎細胞癌、甲状腺様濾胞腎細胞癌、その他にセグメント区分し、腎細胞がん薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・腎細胞がん薬の世界市場概要
・腎細胞がん薬の製造コスト構成分析
・腎細胞がん薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・腎細胞がん薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・腎細胞がん薬のセグメント分析（種類別）
（Sutent（スニチニブ）、Nexavar（ソラフェニブ）、Votrient（パゾパニブ）、Avastin（ベバシズマブ）、Afinitor（エベロリムス）、Inlyta（アキシチニブ）、Torisel（テムシロリムス）、Proleukin（アルデスロイキン））
・腎細胞がん薬のセグメント分析（用途別）
（粘液性尿細管および紡錘細胞癌（MTSCC）、多房性嚢胞性明細胞腎細胞癌、尿細管嚢胞腎細胞癌、甲状腺様濾胞腎細胞癌、その他）
・腎細胞がん薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Merck & Co., Inc.、Exelixis Inc、Argus Therapeutics, Inc.、Bristol-Myers Squibb、Genentech、Immatics Biotechnologies、AVEO Oncology、Eisai、Acceleron、Rexahn Pharmaceuticals、Bionomics、Cerulean Pharma Inc、Celldex Therapeutics、TVAX Biomedical、TRACON Pharmaceuticals、）
・腎細胞がん薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Renal Cell Cacinoma Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Renal Cell Cacinoma Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Renal Cell Cacinoma Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Renal Cell Cacinoma Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Renal Cell Cacinoma Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck & Co., Inc.
Exelixis Inc
Argus Therapeutics, Inc.
Bristol-Myers Squibb
Genentech
Immatics Biotechnologies
AVEO Oncology
Eisai
Acceleron
Rexahn Pharmaceuticals
Bionomics
Cerulean Pharma Inc
Celldex Therapeutics
TVAX Biomedical
TRACON Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Sutent(Sunitinib)
Nexavar(Sorafenib)
Votrient(Pazopanib)
Avastin(Bevacizumab)
Afinitor(Everolimus)
Inlyta(Axitinib)
Torisel(Temsirolimus)
Proleukin(Aldesleukin)

Segment by Application
Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
Multilocular Cystic Clear Cell Renal Cell Carcinoma
Tubulocystic Renal Cell Carcinoma
Thyroid-Like Follicular Renal Cell Carcinoma
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Renal Cell Cacinoma Drugs
1.1 Definition of Renal Cell Cacinoma Drugs
1.2 Renal Cell Cacinoma Drugs Segment by Type
1.2.1 Global Renal Cell Cacinoma Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Sutent(Sunitinib)
1.2.3 Nexavar(Sorafenib)
1.2.4 Votrient(Pazopanib)
1.2.5 Avastin(Bevacizumab)
1.2.6 Afinitor(Everolimus)
1.2.7 Inlyta(Axitinib)
1.2.8 Torisel(Temsirolimus)
1.2.9 Proleukin(Aldesleukin)
1.3 Renal Cell Cacinoma Drugs Segment by Applications
1.3.1 Global Renal Cell Cacinoma Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
1.3.3 Multilocular Cystic Clear Cell Renal Cell Carcinoma
1.3.4 Tubulocystic Renal Cell Carcinoma
1.3.5 Thyroid-Like Follicular Renal Cell Carcinoma
1.3.6 Others
1.4 Global Renal Cell Cacinoma Drugs Overall Market
1.4.1 Global Renal Cell Cacinoma Drugs Revenue (2014-2025)
1.4.2 Global Renal Cell Cacinoma Drugs Production (2014-2025)
1.4.3 North America Renal Cell Cacinoma Drugs Status and Prospect (2014-2025)
1.4.4 Europe Renal Cell Cacinoma Drugs Status and Prospect (2014-2025)
1.4.5 China Renal Cell Cacinoma Drugs Status and Prospect (2014-2025)
1.4.6 Japan Renal Cell Cacinoma Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Renal Cell Cacinoma Drugs Status and Prospect (2014-2025)
1.4.8 India Renal Cell Cacinoma Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Renal Cell Cacinoma Drugs
2.3 Manufacturing Process Analysis of Renal Cell Cacinoma Drugs
2.4 Industry Chain Structure of Renal Cell Cacinoma Drugs

3 Development and Manufacturing Plants Analysis of Renal Cell Cacinoma Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Renal Cell Cacinoma Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Renal Cell Cacinoma Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Renal Cell Cacinoma Drugs Production and Capacity Analysis
4.2 Renal Cell Cacinoma Drugs Revenue Analysis
4.3 Renal Cell Cacinoma Drugs Price Analysis
4.4 Market Concentration Degree

5 Renal Cell Cacinoma Drugs Regional Market Analysis
5.1 Renal Cell Cacinoma Drugs Production by Regions
5.1.1 Global Renal Cell Cacinoma Drugs Production by Regions
5.1.2 Global Renal Cell Cacinoma Drugs Revenue by Regions
5.2 Renal Cell Cacinoma Drugs Consumption by Regions
5.3 North America Renal Cell Cacinoma Drugs Market Analysis
5.3.1 North America Renal Cell Cacinoma Drugs Production
5.3.2 North America Renal Cell Cacinoma Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Renal Cell Cacinoma Drugs Import and Export
5.4 Europe Renal Cell Cacinoma Drugs Market Analysis
5.4.1 Europe Renal Cell Cacinoma Drugs Production
5.4.2 Europe Renal Cell Cacinoma Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Renal Cell Cacinoma Drugs Import and Export
5.5 China Renal Cell Cacinoma Drugs Market Analysis
5.5.1 China Renal Cell Cacinoma Drugs Production
5.5.2 China Renal Cell Cacinoma Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Renal Cell Cacinoma Drugs Import and Export
5.6 Japan Renal Cell Cacinoma Drugs Market Analysis
5.6.1 Japan Renal Cell Cacinoma Drugs Production
5.6.2 Japan Renal Cell Cacinoma Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Renal Cell Cacinoma Drugs Import and Export
5.7 Southeast Asia Renal Cell Cacinoma Drugs Market Analysis
5.7.1 Southeast Asia Renal Cell Cacinoma Drugs Production
5.7.2 Southeast Asia Renal Cell Cacinoma Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Renal Cell Cacinoma Drugs Import and Export
5.8 India Renal Cell Cacinoma Drugs Market Analysis
5.8.1 India Renal Cell Cacinoma Drugs Production
5.8.2 India Renal Cell Cacinoma Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Renal Cell Cacinoma Drugs Import and Export

6 Renal Cell Cacinoma Drugs Segment Market Analysis (by Type)
6.1 Global Renal Cell Cacinoma Drugs Production by Type
6.2 Global Renal Cell Cacinoma Drugs Revenue by Type
6.3 Renal Cell Cacinoma Drugs Price by Type

7 Renal Cell Cacinoma Drugs Segment Market Analysis (by Application)
7.1 Global Renal Cell Cacinoma Drugs Consumption by Application
7.2 Global Renal Cell Cacinoma Drugs Consumption Market Share by Application (2014-2019)

8 Renal Cell Cacinoma Drugs Major Manufacturers Analysis
8.1 Merck & Co., Inc.
8.1.1 Merck & Co., Inc. Renal Cell Cacinoma Drugs Production Sites and Area Served
8.1.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.1.3 Merck & Co., Inc. Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Exelixis Inc
8.2.1 Exelixis Inc Renal Cell Cacinoma Drugs Production Sites and Area Served
8.2.2 Exelixis Inc Product Introduction, Application and Specification
8.2.3 Exelixis Inc Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Argus Therapeutics, Inc.
8.3.1 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production Sites and Area Served
8.3.2 Argus Therapeutics, Inc. Product Introduction, Application and Specification
8.3.3 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bristol-Myers Squibb
8.4.1 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production Sites and Area Served
8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.4.3 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Genentech
8.5.1 Genentech Renal Cell Cacinoma Drugs Production Sites and Area Served
8.5.2 Genentech Product Introduction, Application and Specification
8.5.3 Genentech Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Immatics Biotechnologies
8.6.1 Immatics Biotechnologies Renal Cell Cacinoma Drugs Production Sites and Area Served
8.6.2 Immatics Biotechnologies Product Introduction, Application and Specification
8.6.3 Immatics Biotechnologies Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 AVEO Oncology
8.7.1 AVEO Oncology Renal Cell Cacinoma Drugs Production Sites and Area Served
8.7.2 AVEO Oncology Product Introduction, Application and Specification
8.7.3 AVEO Oncology Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Eisai
8.8.1 Eisai Renal Cell Cacinoma Drugs Production Sites and Area Served
8.8.2 Eisai Product Introduction, Application and Specification
8.8.3 Eisai Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Acceleron
8.9.1 Acceleron Renal Cell Cacinoma Drugs Production Sites and Area Served
8.9.2 Acceleron Product Introduction, Application and Specification
8.9.3 Acceleron Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Rexahn Pharmaceuticals
8.10.1 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production Sites and Area Served
8.10.2 Rexahn Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Bionomics
8.12 Cerulean Pharma Inc
8.13 Celldex Therapeutics
8.14 TVAX Biomedical
8.15 TRACON Pharmaceuticals

9 Development Trend of Analysis of Renal Cell Cacinoma Drugs Market
9.1 Global Renal Cell Cacinoma Drugs Market Trend Analysis
9.1.1 Global Renal Cell Cacinoma Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Renal Cell Cacinoma Drugs Regional Market Trend
9.2.1 North America Renal Cell Cacinoma Drugs Forecast 2019-2025
9.2.2 Europe Renal Cell Cacinoma Drugs Forecast 2019-2025
9.2.3 China Renal Cell Cacinoma Drugs Forecast 2019-2025
9.2.4 Japan Renal Cell Cacinoma Drugs Forecast 2019-2025
9.2.5 Southeast Asia Renal Cell Cacinoma Drugs Forecast 2019-2025
9.2.6 India Renal Cell Cacinoma Drugs Forecast 2019-2025
9.3 Renal Cell Cacinoma Drugs Market Trend (Product Type)
9.4 Renal Cell Cacinoma Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Renal Cell Cacinoma Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Renal Cell Cacinoma Drugs
Table Global Renal Cell Cacinoma Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Renal Cell Cacinoma Drugs Production Market Share by Types in 2018
Figure Sutent(Sunitinib) Product Picture
Figure Nexavar(Sorafenib) Product Picture
Figure Votrient(Pazopanib) Product Picture
Figure Avastin(Bevacizumab) Product Picture
Figure Afinitor(Everolimus) Product Picture
Figure Inlyta(Axitinib) Product Picture
Figure Torisel(Temsirolimus) Product Picture
Figure Proleukin(Aldesleukin) Product Picture
Table Global Renal Cell Cacinoma Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Renal Cell Cacinoma Drugs Consumption Market Share by Applications in 2018
Figure Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
Figure Multilocular Cystic Clear Cell Renal Cell Carcinoma
Figure Tubulocystic Renal Cell Carcinoma
Figure Thyroid-Like Follicular Renal Cell Carcinoma
Figure Others
Figure Global Renal Cell Cacinoma Drugs Revenue (Million USD) (2014-2025)
Figure Global Renal Cell Cacinoma Drugs Production (K Pcs) (2014-2025)
Figure North America Renal Cell Cacinoma Drugs Market Size (Million USD) (2014-2025)
Figure Europe Renal Cell Cacinoma Drugs Market Size (Million USD) (2014-2025)
Figure China Renal Cell Cacinoma Drugs Market Size (Million USD) (2014-2025)
Figure Japan Renal Cell Cacinoma Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Renal Cell Cacinoma Drugs Market Size (Million USD) (2014-2025)
Figure India Renal Cell Cacinoma Drugs Market Size (Million USD) (2014-2025)
Table Renal Cell Cacinoma Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Renal Cell Cacinoma Drugs in 2018
Figure Manufacturing Process Analysis of Renal Cell Cacinoma Drugs
Figure Industry Chain Structure of Renal Cell Cacinoma Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Renal Cell Cacinoma Drugs Manufacturing Plants Distribution
Table Renal Cell Cacinoma Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Renal Cell Cacinoma Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Renal Cell Cacinoma Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Renal Cell Cacinoma Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Renal Cell Cacinoma Drugs Production Share by Manufacturers in 2018
Table Renal Cell Cacinoma Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Renal Cell Cacinoma Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Renal Cell Cacinoma Drugs Revenue Share by Manufacturers in 2018
Table Renal Cell Cacinoma Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Renal Cell Cacinoma Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Renal Cell Cacinoma Drugs Production Market Share by Regions 2014-2019
Figure Global Renal Cell Cacinoma Drugs Production Market Share by Regions in 2018
Table Global Renal Cell Cacinoma Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Renal Cell Cacinoma Drugs Revenue Market Share by Regions 2014-2019
Figure Global Renal Cell Cacinoma Drugs Revenue Market Share by Regions in 2018
Table Global Renal Cell Cacinoma Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Renal Cell Cacinoma Drugs Consumption Market Share by Regions 2014-2019
Figure North America Renal Cell Cacinoma Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Renal Cell Cacinoma Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Renal Cell Cacinoma Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Renal Cell Cacinoma Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Renal Cell Cacinoma Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Renal Cell Cacinoma Drugs Production, Consumption Import and Export (K Pcs)
Figure China Renal Cell Cacinoma Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Renal Cell Cacinoma Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Renal Cell Cacinoma Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Renal Cell Cacinoma Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Renal Cell Cacinoma Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Renal Cell Cacinoma Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Renal Cell Cacinoma Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Renal Cell Cacinoma Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Renal Cell Cacinoma Drugs Production, Consumption Import and Export (K Pcs)
Figure India Renal Cell Cacinoma Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Renal Cell Cacinoma Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Renal Cell Cacinoma Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Renal Cell Cacinoma Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Renal Cell Cacinoma Drugs Market Share by Application (2014-2019)
Table Merck & Co., Inc. Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Merck & Co., Inc. Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Merck & Co., Inc. Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Merck & Co., Inc. Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Exelixis Inc Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Exelixis Inc Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Exelixis Inc Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Exelixis Inc Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Exelixis Inc Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Exelixis Inc Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Exelixis Inc Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Bristol-Myers Squibb Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Genentech Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Genentech Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Genentech Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genentech Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Genentech Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Genentech Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Genentech Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Immatics Biotechnologies Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Immatics Biotechnologies Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Immatics Biotechnologies Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immatics Biotechnologies Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Immatics Biotechnologies Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Immatics Biotechnologies Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Immatics Biotechnologies Renal Cell Cacinoma Drugs Main Business and Markets Served
Table AVEO Oncology Renal Cell Cacinoma Drugs Production Sites and Area Served
Table AVEO Oncology Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table AVEO Oncology Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AVEO Oncology Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table AVEO Oncology Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure AVEO Oncology Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table AVEO Oncology Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Eisai Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Eisai Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Eisai Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Eisai Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Eisai Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Eisai Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Acceleron Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Acceleron Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Acceleron Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Acceleron Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Acceleron Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Acceleron Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Acceleron Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
Table Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
Table Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production Market Share (2014-2019)
Figure Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Revenue Market Share (2014-2019)
Table Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Main Business and Markets Served
Table Bionomics Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Cerulean Pharma Inc Renal Cell Cacinoma Drugs Production Sites and Area Served
Table Celldex Therapeutics Renal Cell Cacinoma Drugs Production Sites and Area Served
Table TVAX Biomedical Renal Cell Cacinoma Drugs Production Sites and Area Served
Table TRACON Pharmaceuticals Renal Cell Cacinoma Drugs Production Sites and Area Served
Figure Global Renal Cell Cacinoma Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Renal Cell Cacinoma Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Renal Cell Cacinoma Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Renal Cell Cacinoma Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Renal Cell Cacinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Renal Cell Cacinoma Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Renal Cell Cacinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Renal Cell Cacinoma Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Renal Cell Cacinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Renal Cell Cacinoma Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Renal Cell Cacinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Renal Cell Cacinoma Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Renal Cell Cacinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Renal Cell Cacinoma Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Renal Cell Cacinoma Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Renal Cell Cacinoma Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Renal Cell Cacinoma Drugs by Application (2019-2025)
Table Renal Cell Cacinoma Drugs Distributors List
Table Renal Cell Cacinoma Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Merck & Co., Inc.、Exelixis Inc、Argus Therapeutics, Inc.、Bristol-Myers Squibb、Genentech、Immatics Biotechnologies、AVEO Oncology、Eisai、Acceleron、Rexahn Pharmaceuticals、Bionomics、Cerulean Pharma Inc、Celldex Therapeutics、TVAX Biomedical、TRACON Pharmaceuticals、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の腎細胞がん薬市場(Global Renal Cell Cacinoma Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp